Form 4: BioLife Solutions CHRO Executes Pre-Planned Stock Sale

Sarah Aebersold, Chief Human Resources Officer at BioLife Solutions Inc., sold 714 shares of common stock for $25.61 per share on September 15, 2025, as part of a Rule 10b5-1 trading plan.

Summary

• Sarah Aebersold, the Chief Human Resources Officer of BioLife Solutions Inc. (BLFS), reported a transaction.
• The transaction involved the sale of 714 shares of common stock.
• The shares were sold at a price of $25.61 per share.
• The transaction date was September 15, 2025.
• Following this transaction, Sarah Aebersold directly beneficially owns 77,357 shares of common stock.
• The sale was executed pursuant to a Rule 10b5-1(c) trading plan, which became effective on December 11, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a pre-scheduled insider stock sale under a Rule 10b5-1 plan, which typically does not reflect a change in management's outlook on the company's prospects.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing reports a routine insider stock transaction under a pre-arranged trading plan, which is a common practice among corporate executives to manage their equity holdings and diversify their portfolios while complying with insider trading regulations. It does not provide insights into broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in insider ownership, but given it's a 10b5-1 plan, it's generally not interpreted as a negative signal regarding the company's future.

Key Dates

Keywords

BioLife Solutions, BLFS, Sarah Aebersold, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Chief Human Resources Officer